Stereotactic Body Radiation Therapy (SBRT)

Stereotactic body radiation therapy (SBRT), or stereotactic ablative radiotherapy, is a type of radiation therapy that precisely targets a tumor with high doses of radiation by using several beams of various intensities aimed at different angles.

Elekta Instrument AB recalls disposable biopsy needle kit for Leksell Stereotactic System for possibly containing microscopic stainless steel febris on the inside of the biopsy needle
News | FDA
FDA Announces Elekta Recall of Biopsy Needle Kit for Leksell Stereotactic System

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
Multi-center study achieves durable local control and cancer-specific survival after stereotactic radiation treatment
News | Stereotactic Body Radiation Therapy (SBRT)
High-dose Radiation Offers New Treatment Option for Older Patients with Inoperable Kidney Tumors

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

Time October 01, 2023
arrow
Centre de Cancérologie de la Porte de Saint-Cloud in Boulogne unveils the latest advance in completely non-invasive brain tumor therapy
News | Radiation Oncology
First ZAP-X Gyroscopic Radiosurgery Treatments Commence in France

May 23, 2023 — ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that ...

Time May 23, 2023
arrow
RTsafe’s PseudoPatient that is used to verify radiotherapy dosage and accuracy ahead of patient treatment.
News | Quality Assurance (QA)
RTsafe Announces First Use of its PseudoPatient Patient-specific Quality Assurance Process by Fundación Instituto Valenciano de Oncología (IVO)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
Derry Crighton, one of the first patients to be treated last week with the new Elekta Esprit, a Leksell Gamma Knife stereotactic radiosurgery (SRS) system, at the National Centre for Stereotactic Radiosurgery in Sheffield, UK
News | Radiation Oncology
First Gamma Knife Esprit Patient Resumes Life as Usual Only Days After Brain Surgery

February 17, 2023 — Derry Crighton, a father of three from Scotland, says the Elekta Esprit radiosurgery system used to ...

Time February 17, 2023
arrow
Elekta announced that it has received CE mark for its Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform.
News | Radiation Therapy
Elekta’s New Radiosurgery System, Elekta Esprit, Receives CE Mark

August 23, 2022 — Elekta announced that it has received CE mark for its Elekta Esprit, a new Leksell Gamma Knife ...

Time August 23, 2022
arrow
Above a certain size, individual brain metastases are often surgically removed with the help of microsurgical resection. In stereotactic radiosurgery (SRS), in contrast, they are usually treated with a single high-dose targeted radiation using cobalt-60-gamma radiation sources.
News | Radiation Therapy
Stereotactic Radiosurgery in Brain Metastases

March 15, 2022 — Above a certain size, individual brain metastases are often surgically removed with the help of ...

Time March 15, 2022
arrow
Sponsored Content | Sponsored Content | Videos | Radiation Therapy
Talking Trends: Perfect Balance with Elekta Harmony

Elekta’s latest linear accelerator, Harmony, is designed to provide a productive and versatile radiotherapy solution for ...

Time February 16, 2022
arrow
UVA Cancer Center's David Schiff, MD, co-chaired a blue-ribbon panel that developed important new guidelines for treating brain metastases — cancers that have spread to the brain. Image courtesy of UVA Health
News | Radiation Oncology
New Brain Cancer Guidelines to Improve Care, Patient Survival

January 27, 2022 — New guidelines for treating cancers that have spread to the brain are poised to improve care for ...

Time January 27, 2022
arrow
Videos | Radiation Therapy
VIDEO: Elekta Harmony Radiotherapy System Walk-around

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
Steven Chmura, M.D., Ph.D., University of Chicago, speaks at an ASTRO 2021 press conference on the results of a phase 1 clinical trial testing the effects of stereotactic body radiotherapy for treating multiple metastases. His study determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. Read more on this study.
Feature | ASTRO
Radiation Oncology Research Featured at ASTRO 2021

November 8, 2021 — The following links to all the highlighted sessions presented at the American Society for Radiation ...

Time November 08, 2021
arrow
News | Stereotactic Body Radiation Therapy (SBRT)
Serial Radiation Therapy is Safe and Effective as Alternative Treatment to Systemic Therapy for Kidney Cancer

October 29, 2021 — In a new single-arm study, researchers at The University of Texas MD Anderson Cancer Center reported ...

Time October 29, 2021
arrow
Elekta Harmony radiation therapy system at ASTRO 2021.
360 Photos | Radiation Therapy
360 Degree View of the Harmony Radiation Therapy System at ASTRO 2021

This is a virtual tour of the New Elekta Harmony radiation therapy system at the American Society of Radiation Oncology ...

Time October 28, 2021
arrow
ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society, held October 24-27, 2021 in Chicago.
News | Stereotactic Body Radiation Therapy (SBRT)
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients

October 28, 2021 — ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer ...

Time October 28, 2021
arrow
High-dose radiation therapy can be used to lengthen progression-free survival for people with advanced lung cancer when systemic therapy has not fully halted the growth or spread of metastases, according to a new study.
News | Stereotactic Body Radiation Therapy (SBRT)
High-dose Radiation Thwarts Tumor Growth in Patients with Advanced Lung Cancer

October 24, 2021 — High-dose radiation therapy can be used to lengthen progression-free survival for people with ...

Time October 24, 2021
arrow
RefleXion is developing biology-guided radiotherapy* (BgRT), which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT).
News | Radiation Oncology
RefleXion Announces Newly Formed Scientific Advisory Board

October 20, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) as a ...

Time October 20, 2021
arrow
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA)
Sun Nuclear Highlights Expanded Machine QA Capabilities

September 2, 2021 — At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive ...

Time September 02, 2021
arrow
Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration
News | Linear Accelerators
Elekta Harmony Radiation Therapy System Receives FDA Approval

June 18, 2021 — Elekta announced that its Elekta Harmony radiation therapy system recently received U.S. FDA 510(k) ...

Time June 18, 2021
arrow
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.
News | Stereotactic Body Radiation Therapy (SBRT)
Study Finds Stereotactic Body Radiotherapy Safe for Treating Patients with Multiple Metastases

April 23, 2021 — A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects ...

Time April 23, 2021
arrow
“Distinction in Stereotactic Radiotherapy” offers comprehensive accreditation program for SRS/SBRT clinical practice and physics quality assurance
News | Stereotactic Body Radiation Therapy (SBRT)
The Radiosurgery Society Announces Launch of Joint Accreditation Program with The American College of Radiation Oncology

February 26, 2021 — The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and ...

Time February 26, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now